These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 648078)

  • 1. Furosemide kinetics in renal failure.
    Tilstone WJ; Fine A
    Clin Pharmacol Ther; 1978 Jun; 23(6):644-50. PubMed ID: 648078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elimination of furosemide in healthy subjects and in those with renal failure.
    Beermann B; Dalén E; Lindström B
    Clin Pharmacol Ther; 1977 Jul; 22(1):70-8. PubMed ID: 872498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of furosemide in man after intravenous and oral administration. Application of moment analysis.
    Hammarlund MM; Paalzow LK; Odlind B
    Eur J Clin Pharmacol; 1984; 26(2):197-207. PubMed ID: 6723758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of furosemide in advanced renal failure.
    Huang CM; Atkinson AJ; Levin M; Levin NW; Quintanilla A
    Clin Pharmacol Ther; 1974 Oct; 16(4):659-66. PubMed ID: 4422027
    [No Abstract]   [Full Text] [Related]  

  • 5. Absorption and disposition of furosemide in congestive heart failure.
    Brater DC; Seiwell R; Anderson S; Burdette A; Dehmer GJ; Chennavasin P
    Kidney Int; 1982 Aug; 22(2):171-6. PubMed ID: 7132061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of furosemide in patients with congestive heart failure.
    Greither A; Goldman S; Edelen JS; Benet LZ; Cohn K
    Pharmacology; 1979; 19(3):121-31. PubMed ID: 523503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of probenecid on furosemide kinetics and natriuresis in man.
    Honari J; Blair AD; Cutler RE
    Clin Pharmacol Ther; 1977 Oct; 22(4):395-401. PubMed ID: 902452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-dependent pharmacokinetics of furosemide in the rat.
    Hammarlund MM; Paalzow LK
    Biopharm Drug Dispos; 1982; 3(4):345-59. PubMed ID: 7159689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Furosemide disposition in cirrhotic patients.
    Sawhney VK; Gregory PB; Swezey SE; Blaschke TF
    Gastroenterology; 1981 Dec; 81(6):1012-6. PubMed ID: 7286579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of frusemide in chronic renal failure.
    Fine A; Kennedy AC; Tilstone WJ
    Proc Eur Dial Transplant Assoc; 1976; 12():338-43. PubMed ID: 935124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Furosemide disposition in patients on CAPD.
    Martin U; Winney RJ; Prescott LF
    Eur J Clin Pharmacol; 1995; 48(5):385-90. PubMed ID: 8641327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition and absolute bioavailability of furosemide in healthy males.
    Waller ES; Hamilton SF; Massarella JW; Sharanevych MA; Smith RV; Yakatan GJ; Doluisio JT
    J Pharm Sci; 1982 Oct; 71(10):1105-8. PubMed ID: 7143205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of intraindividual variability in bioavailability studies of furosemide.
    Grahnén A; Hammarlund M; Lundqvist T
    Eur J Clin Pharmacol; 1984; 27(5):595-602. PubMed ID: 6519165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digoxin bioavailability: formulations and rates of infusions.
    Marcus FI; Dickerson J; Pippin S; Stafford M; Bressler R
    Clin Pharmacol Ther; 1976 Sep; 20(3):253-9. PubMed ID: 954346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of furosemide in children with chronic renal failure undergoing regular haemodialysis.
    Riva E; Fossali E; Bettinelli A
    Eur J Clin Pharmacol; 1982; 21(4):303-6. PubMed ID: 7056274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Furosemide kinetics and dynamics after kidney transplant.
    Smith DE; Gambertoglio JG; Vincenti F; Benet LZ
    Clin Pharmacol Ther; 1981 Jul; 30(1):105-13. PubMed ID: 7016396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition kinetics of furosemide in dogs.
    El-Sayed MG; Atef M; El-Gendi AY; Youssef SA
    Arch Int Pharmacodyn Ther; 1981 Sep; 253(1):4-10. PubMed ID: 7325754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steady state absorption kinetics and pharmacodynamics of furosemide in congestive heart failure.
    Chaturvedi PR; O'Donnell JP; Nicholas JM; Shoenthal DR; Waters DH; Gwilt PR
    Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):123-8. PubMed ID: 3557737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the fate of furosemide in man.
    Beermann B; Dalén E; Lindström B; Rosén A
    Eur J Clin Pharmacol; 1975 Oct; 9(1):51-61. PubMed ID: 1233253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pindolol availability in hypertensive patients with normal and impaired renal function.
    Chau NP; Weiss YA; Safar ME; Lavene DE; Georges DR; Milliez PL
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):505-10. PubMed ID: 913016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.